{"entities":{"Q84386":{"pageid":85651,"ns":120,"title":"Item:Q84386","lastrevid":84588194,"modified":"2026-05-26T19:04:31Z","type":"item","id":"Q84386","labels":{"en":{"language":"en","value":"Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q84386$318E451A-F2C4-46EC-838C-86E053F361A7","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"401e9a79442252be7cd58ef039cb41040e6ce88a","datavalue":{"value":"10.1177/009286150804200402","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q84386$7753CF27-9178-4FFC-AAD9-1F583AE043EA","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"5b2733decfc5b7253fc86f1c2b86342c94eb9339","datavalue":{"value":{"entity-type":"item","numeric-id":84380,"id":"Q84380"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q84386$A4972255-AC62-4DAB-B658-B4AB08EBF4A9","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"d8b79f80d987ff4a11bd1c7e49b3ba5c4b5d575d","datavalue":{"value":"42","type":"string"},"datatype":"string"},"type":"statement","id":"Q84386$A9B10ED1-6572-400C-AB53-9C3D68FAD0E5","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"133c4f1f6faefb140213d67b06b427618fdbf331","datavalue":{"value":"4","type":"string"},"datatype":"string"},"type":"statement","id":"Q84386$620ED328-28A3-463B-993C-0765B08C41CA","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"72d0d4c3e6f752e55dda98aef87f9d748c890da4","datavalue":{"value":"303-319","type":"string"},"datatype":"string"},"type":"statement","id":"Q84386$B63C6E26-B5D7-4A55-8C86-BCDCAAB9F33E","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"f3dd40934eae22d74c23f1b5c82912f21bd49c53","datavalue":{"value":{"time":"+2008-07-00T00:00:00Z","timezone":0,"before":0,"after":0,"precision":10,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q84386$36071BF3-7765-4EE9-BD0D-14F327C25DBB","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q84386$AF26552B-ED3C-43ED-9993-6B73448B0146","rank":"normal"}],"P43":[{"mainsnak":{"snaktype":"value","property":"P43","hash":"6addb2fe647a19bdb8e4dde7d07bc53f7f4b971e","datavalue":{"value":"Craig H. Mallinckrodt","type":"string"},"datatype":"string"},"type":"statement","id":"Q84386$EF9002FF-C120-4459-BA26-DCA5F19157C7","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"70e9d24fe6bdb54cd41fc91bd59fe89386bef232","datavalue":{"value":"Peter W. Lane","type":"string"},"datatype":"string"},"type":"statement","id":"Q84386$709B8C5F-1A95-48C2-AB31-F6FD46853AFF","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"b2b0a7c75b3a7ba0d6c58a165abbe6b8b1badd3c","datavalue":{"value":"Dan Schnell","type":"string"},"datatype":"string"},"type":"statement","id":"Q84386$576B5C84-098D-4A6C-9B2A-BBBF02881537","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"9236afa444e718c740a8d5d0b72627f724edb58d","datavalue":{"value":"Yahong Peng","type":"string"},"datatype":"string"},"type":"statement","id":"Q84386$D92F4F76-A481-4573-8F89-F175DC86ED7D","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"3ac76182d46a90314b22a701f8ef0d07d96adf9d","datavalue":{"value":"James P. Mancuso","type":"string"},"datatype":"string"},"type":"statement","id":"Q84386$0EDD722F-A612-41CB-AC16-1E8B50A74E45","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/Recommendations_for_the_Primary_Analysis_of_Continuous_Endpoints_in_Longitudinal_Clinical_Trials"}}}}}